Source: Stock image generated with AI.

Key Highlights

  • Mobix Labs reported new six-figure production orders for aircraft engine-system components from a tier-one supplier.
  • The company said its custom connectors help shield engine electronics from electromagnetic interference.
  • Mobix Labs linked the awards to broader demand across U.S. fighter jets and wide-body commercial aircraft.

Mobix Labs, Inc. (Nasdaq: MOBX) said it has received new six-figure production orders from a tier-one global aerospace and defence supplier for advanced engine-system components used across multiple U.S. fighter jet platforms and wide-body commercial aircraft.

According to the company, the orders expand its presence in critical aircraft engine systems, where its custom connectors are designed to protect sensitive engine control and monitoring electronics from electromagnetic interference.

This article is a journalistic opinion piece which has been written based on independent research. It is intended to inform investors and should not be taken as a recommendation or financial advice.

Mobix Labs also pointed to other recent defence-related demand it has disclosed, including a previously announced F-16 production order and what it described as an approximately 500% increase in orders supporting the F-22 Raptor. The company said its aerospace portfolio also supports the F-35 Lightning II and F/A-18 Super Hornet.

In a statement included in the release, Chief Executive Officer Phil Sansone said, “Winning engine-system business orders from tier-one global aerospace suppliers demonstrates the expanding reach of our technology across military and commercial aviation and reinforces our position in some of the world's most demanding aerospace applications.”

The company noted that its outlook for business opportunities, market demand and future orders is subject to risks and uncertainties described in its filings with the U.S. Securities and Exchange Commission.

The original press release is available on stockhouse.com

More From The Market Online

MindBio Therapeutics shares resume trading on CSE

MindBio Therapeutics (CSE: MBIO) resumed trading after a halt, with CIRO listing a Nov. 5, 2026 resumption time of 11:15 am ET.

Fairchild Gold outlines new Golden Arrow gold-silver targets from satellite survey

Fairchild Gold reported TerraEye satellite survey results at Golden Arrow in Nevada, outlining nine gold-silver targets and planned field verification.
TSX Jumps 2.28% as AI Stocks Slide, Wendy’s Fights Bid

Market Open: TSX Jumps 2.28% as AI Stocks Slide and Wendy’s Rejects Buyout | Nov 5th

The TSX jumped 2.28% while the Nasdaq fell 2.64% on an AI selloff, and Wendy’s rejected an activist buyout with a poison pill.